Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiation therapy after prostatectomy: now or later?

S E Schild1

  • 1Department of Radiation Oncology, Mayo Clinic, Scottsdale, AZ 85259, USA.

Seminars in Radiation Oncology
|April 29, 1998
PubMed
Summary

Men with advanced prostate cancer (stage T3/T4) face recurrence risk after surgery. Rising PSA levels signal recurrence, but radiation therapy offers salvage, with 30-54% success rates. Combined therapies may improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiation recall dermatitis: A review of the literature.

Seminars in oncology·2022
Same author

Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?

OMICS journal of radiology·2019
Same author

Predictors of survival in patients with brain metastases from gastric cancer.

Neoplasma·2016
Same author

Pathways to improving combined modality therapy for stage III nonsmall-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2015
Same author

A new prognostic factor for the survival of patients with renal cell carcinoma developing metastatic spinal cord compression.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014
Same author

Predicting the presence of extracranial metastases in patients with brain metastases upon first diagnosis of cancer.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2014

Area of Science:

  • Oncology
  • Urology
  • Radiation Oncology

Background:

  • Pathological stage T3 or T4 prostate cancers after radical retropubic prostatectomy (RRP) carry a significant risk of cancer recurrence.
  • Rising prostate-specific antigen (PSA) levels post-RRP are the earliest indicator of recurrence, preceding clinical detection by months to years.

Purpose of the Study:

  • To evaluate the efficacy of radiation therapy in reducing failure risk for patients with advanced prostate cancer post-RRP.
  • To explore the potential of salvage radiation therapy for patients with rising PSA levels after RRP.

Main Methods:

  • Review of existing studies and patient data on adjuvant and salvage radiation therapy for prostate cancer recurrence.
  • Analysis of reported success rates for radiation therapy in salvaging patients with rising PSA levels post-RRP.

Main Results:

  • Adjuvant radiation therapy significantly reduces the risk of failure in high-risk prostate cancer patients.
  • Salvage radiation therapy can successfully treat 30% to 54% of carefully staged patients with rising PSA levels after RRP.

Conclusions:

  • Radiation therapy is an effective treatment for prostate cancer recurrence after RRP, both as an adjuvant and salvage modality.
  • Combined radiation and hormonal therapy may offer improved salvage rates in the future.
  • Ongoing studies aim to determine the optimal timing and approach (adjuvant vs. salvage) for radiation therapy in managing prostate cancer recurrence.

Related Experiment Videos